Clinical trial begins for promising HIV cure developed by Temple scientists

Scientists at Temple University have begun a clinical trial to test the safety and efficacy of a promising cure for HIV. The treatment, based on breakthrough CRISPR technology, uses gene-editing to eradicate the genetic material of the human immunodeficiency virus from infected cells.

Leave a Reply